] i ) and acts as a major signaling pathway (Ca 2ϩ -dependent mechanism) mediating vascular contraction (5, 27) . Other signaling pathways coupled to ␣ 1 -AR include activation of protein kinase C (PKC) and extracellular signal-regulated kinases 1 and 2 (ERK1/2) (Ca 2ϩ sensitization/independent mechanism) mediating vascular contraction (4, 22) . Our previous studies (51, 52) have shown that ␣ 1 -AR-mediated contraction of CA occurs by both Ca 2ϩ -dependent and Ca 2ϩ -independent mechanisms. We also have shown that in ovine CA adrenergic-mediated vasoconstrictor responses differ significantly in fetus and adult (27, 28, 51, 52) . Recently, we have shown (8) significant changes in the Ca 2ϩ sensitization pathway (PKC and ERK1/2) with developmental maturation from fetus to adult.
Radioligand binding and molecular cloning in several species have demonstrated that the ␣ 1 -AR family has three structurally distinct subtypes (␣ 1A , ␣ 1B , ␣ 1D ), which are widely expressed in tissues and have different pharmacological properties and amino acid sequences (36, 53) . Although the three ␣ 1 -adrenoceptor subtypes have been reported in various cell types, little is known about their expression, physiological functions, or downstream pathways in CA (20, 22, 53) . Of note, in fetal and adult CA we have demonstrated differing roles of NE (␣ 1 -and ␣ 2 -AR agonist) and phenylephrine (Phe; ␣ 1 -AR agonist) in contractility and downstream activation of PKC and ERKs (8, 29, 51, 52) . Thus the question arises as to the role of the specific ␣ 1 -AR subtypes and the role of downstream effectors in ␣-adrenergic-mediated contraction in CA, and their changes with maturation. In the present study, we tested the hypothesis that in CA differential expression and activation of ␣ 1 -AR subtypes (␣ 1A -, ␣ 1B -, and ␣ 1D -AR), in fetus compared with adult differentially activate downstream signaling pathway responsible for contractile response and/or growth and development. The present study provides a deeper understanding of CBF regulation during fetal and adult life and provides more specific targets for treatment of conditions such as dysregulation of CBF.
lation of 1% isoflurane in oxygen throughout surgery. After the fetus was delivered by hysterotomy, the fetuses and ewes were killed with an overdose of the proprietary euthanasia solution Euthasol (pentobarbital sodium 100 mg/kg and phenytoin sodium 10 mg/kg; Virbac, Fort Worth, TX). Studies were performed in isolated cerebral vessels cleaned of adipose and connective tissue. To avoid the complications of endothelium-mediated effects, we removed the endothelium by carefully inserting a small wire three times, as previously described (26, 28) . The vessels were used immediately for experiments.
Simultaneous measurement of [Ca 2ϩ ]i and tension. We have described this technique in several reports (8, 24 -26, 29) . Briefly, fetal or adult middle CA rings of 2-mm length were incubated at 25°C for 40 min with the acetoxymethyl ester of fura-2 (fura-2 AM; Molecular Probes, Eugene, OR), a fluorescent Ca 2ϩ indicator (24, 25, 26) . After loading the dye, we mounted the arterial segments in a Jasco CAF-110, an intracellular Ca 2ϩ analyzer (Jasco, Easton, MD). We then stabilized CA rings at 38°C for 40 min in an oxygenated standard Krebs solution. The bath chambers were continuously bubbled with 95% O 2-5% CO2, and all experiments were conducted at 38°C (core temperature of sheep). After stabilization, on the basis of our previous studies, the optimum resting tension was 0.6 g for fetal and 0.7 g for adult CA, because at these tensions the contractility response to 125 mM KCl was maximum (28, 39) . We then stimulated the isolated CA rings from fetal and adult sheep with 125 mM KCl, and after the contractile force plateaued 100 M acetylcholine (ACh) was applied. The arteries that relaxed in the presence of ACh were discarded from the study, allowing for the evaluation of the relative quantity of contractile smooth muscle (34) and to determine the status of endothelium disruption (10) . The contractile force due to 125 mM KCl was measured as grams (g) of tension, before stimulation of the test compound for each arterial segment, and was used to normalize the arterial contraction with other agonists and antagonists for variation in the smooth muscle mass (26) . For all vessels we evaluated the contractile response for tension and fluorescence ratio by measuring the maximum peak height and expressing it in both absolute terms and as percent Kmax (a measure of "efficacy"), and calculated pD2 (negative logarithm of EC50, or half-maximal concentration, for NE or Phe and an index of tissue "sensitivity" or "potency") (12, 26) . As we have previously reported, although in absolute terms the maximal values of fetal CA K ϩ -and NE-induced tension are 20 -30% less than those of the adult (25, 26) , expressing these in terms of Kmax helps to normalize the data and does not alter the interpretation of the results. In arteries used for response to a given agonist, i.e., NE (a nonselective agonist for both ␣1-and ␣2-AR) or Phe (a selective agonist for ␣1-AR) and/or selective ␣1-AR (subtype) antagonists, we added the antagonist for 20 min before administration of NE or Phe. Unless otherwise noted, all chemicals were obtained from Sigma Chemical (St. Louis, MO).
Role of ␣1-AR subtype blockers. Three pharmacologically distinct ␣1-AR subtypes can be distinguished with competitive antagonists and alkylating agents. The ␣1A-AR is shown to be inhibited by 2-(2,6-dimethoxyphenoxyethyl)aminomethyl-1,4-benzodioxane hydrochloride (WB-4101) (38) , phentolamine (14) , and 5-methyl-
Moreover, WB-4101 is a noncompetitive antagonist, whereas 5-MU is a competitive antagonist and is more selective than other pharmacological agents for ␣1A-AR (9, 11, 17, 18) . Furthermore, studies have demonstrated that the ␣1B-AR subtype is selectively inhibited by chlorethylclonidine (CEC) (14, 15, 35, 37) . Other studies have established that 8-(2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl)-8-azaspiro(4,5)decane-7,9-dione (BMY-7378) selectively inhibits ␣1D-AR subtype (7, 23, 40, 42) . All of these antagonists are well characterized, with known IC50 for vascular adrenergic receptors. Therefore, on the basis of these studies, we chose 5-MU and WB-4101 for ␣1A-AR, CEC for ␣1B-AR, and BMY-7378 for ␣1D-AR inhibition in the present study. First, using the fixed agonist, we performed dose-response curves with specific ␣1-AR subtype antagonists to determine the pIC50 in sheep CA ( Ins (1, 4, 5) P3 quantification. From each fetal and adult animal, cleaned CA was cut into segments weighing ϳ20 mg (wet wt), placed in Krebs buffer, and bubbled with 95% O 2-5% CO2 for 0.5 h. We exposed the arteries to various treatments outlined above (Phe stimulation with selective ␣ 1-AR subtype inhibition) at 38°C according to the protocol. Reactions were terminated by freezing in liquid N2, the frozen samples were homogenized in 2 ml of iced 16% trichloroacetic acid with a glass grinder and centrifuged for 30 min at 1,500 g, the supernatant was transferred, and the pellet was resuspended in 1 M NaOH for protein measurements (2) . The supernatant was washed for 30 s with H 2O-saturated ether (5ϫ volume, 2 times). After ether evaporation, we determined Ins(1,4,5)P3 mass by competitive ligand binding assay in which a radioactive ligand competes with a nonradioactive ligand for a fixed number of receptor binding sites, as we have described previously (27) . [ 3 H]Ins(1,4,5)P3 assay kits were obtained from DuPont (Boston, MA); intra-and interassay coefficients of variation were 7% and 9%, respectively.
Immunoblot of ␣1-AR subtypes. Isolated CA from fetal and adult sheep were cleaned of adventitia, and endothelium was denuded. These arteries were homogenized with a tissue grinder in ice-cold cell lysis buffer (Cell Signaling Technology, Danvers, MA) as we have described previously (29, 51) . Protein concentrations were measured with a protein assay kit (Bio-Rad Laboratories, Hercules, CA), and bovine serum albumin (BSA) was used as a reference protein (2) . The Mini Trans-Blot Electrophoretic Transfer Cell System (Bio-Rad Laboratories) was used to transfer proteins from the gel to a nitrocellulose membrane at 100 V for 3 h. We then performed an overnight incubation of subtype-specific primary antibodies (1:500 dilution) for ␣ 1A-, ␣1B-, and ␣1D-AR (Santa Cruz Biotechnology, Santa Cruz, CA). We used ␣-actin as an internal control for equal protein loading as well as the blocking peptide for each subtype-specific antibody as a negative control (Santa Cruz Biotechnology). The membrane was then incubated in chemiluminescence luminol reagent (Pierce, Rockford, IL) for 1 min, and the protein band was detected with the Alpha Innotech Chemiluminescent imaging system (San Leandro, CA). After protein detection, the membrane was striped with strip buffer (Pierce) and immunoblotted by anti-␣-actin antibody.
Immunoblotting of ERK1/2. After tension measurement, fetal and adult sheep CA were frozen rapidly in liquid N 2. Frozen samples were homogenized in the 1ϫ cell lysis buffer (Cell Signaling Technology) containing 1ϫ phosphatase inhibitor cocktail and 1 mM phenylmethylsulfonyl fluoride. Nuclei and debris were pelleted by centrifugation at 1,000 g for 10 min. The supernatant was collected and stored at Ϫ80°C. SDS-gel and Western immunoblots were performed, as mentioned above for ␣1-AR immunoblot by using phospho-and total-ERK1/2 antibody (Cell Signaling Technology), as we have described previously (8) .
Statistical analysis. All values were calculated as means Ϯ SE. In all cases, n values refer to the number of vessels (which corresponds to the number of animals and is included in Figs. 1-6 ) for a particular study. Because of the nature of these studies, we used several statistical tests to examine for significant differences. For testing differences between two groups, we used a simple unpaired Student's t-test. For multiple comparisons, we used one-way and two-way analysis of variance (ANOVA; vessel, age) coupled with Duncan's multiple range test. Where appropriate, we used ANOVA with repeated measures (Prism, GraphPad Software, La Jolla, CA). A P value of Ͻ0.05 was considered significant.
RESULTS
Norepinephrine-induced CA contraction through ␣ 1-AR. To establish the extent to which NE mediates its effects through ␣ 1 -AR in both fetal and adult CA, we measured NE-induced contractile and [Ca 2ϩ ] i responses in the presence and absence of the ␣ 1 -AR antagonist prazosin (selective ␣ 1 -AR blocker). As seen in Fig. 1 , in the presence of prazosin (10 Ϫ8 M), the pD 2 values for NE responses of tension and fluorescence ratio for both adult and fetal vessels were significantly decreased by Ͼ1 log unit. Also, as shown in Table 2 , in both fetal and adult CA, the dissociation constants (K B values) for prazosin-mediated inhibition of NE-induced vascular contraction and [Ca 2ϩ ] i responses were similar, suggesting that both events were mediated by the ␣ 1 -AR. ] i responses in the presence and absence of ␣ 1A -AR antagonist 5-MU (10 Ϫ8 M). As shown in Fig. 2 , in the presence of 5-MU both fetal and adult CA showed a significant right shift of the Phe doseresponse curve for contraction (Fig. 2, A and D) , as well as increases in [Ca 2ϩ ] i (Fig. 2 , B and E; see Table 2 for K B values and Fig. 2 for pD 2 values) . This demonstrates that in both fetal and adult CA ␣ 1A -AR play a significant role in Phe-induced contractile response, acting through a Ca 2ϩ -dependent pathway. Moreover, 5-MU had a greater effect in fetal CA compared with that in adult CA. To confirm this possibility further, we used a different ␣ 1A -AR antagonist, WB-4101 (10 Ϫ7 M), to test Phe-induced tension and [Ca 2ϩ ] i responses in another series of CA. As shown in Fig. 2F for adult CA, the tension responses were similar to those in the presence of 5-MU (see Table 2 for K B values). For fetal CA (Fig. 2C) , the K B value for the effect of WB-4101 on tension was similar to that of adult CA (Table 2) .
To examine the effect of ␣ 1B -AR inhibition on Phe concentration-response curves, we performed a Phe dose-response curve in the presence and absence of the ␣ 1B -AR antagonist CEC (10 Ϫ5 M). In adult CA, in the presence of CEC (10 Ϫ5 M) both tension (Fig. 3C ) and [Ca 2ϩ ] i (Fig. 3D) were significantly right-shifted. In contrast, in fetal CA 10 Ϫ5 M CEC had no significant effect on the Phe-induced vascular tension (Fig. 3A ) and only modestly right-shifted the Phe dose response for [Ca 2ϩ ] i (Fig. 3B) ; see Table 2 for CEC K B values. Thus in fetal CA, ␣ 1B -AR has significantly less role in Phe-induced contractile response compared with adult CA.
To determine the extent to which ␣ 1D -AR inhibition altered Phe-induced tension and [Ca 2ϩ ] i responses, we measured these variables in response to increasing doses of Phe (10 Ϫ9 -10 Ϫ2 M) in the absence or presence of the ␣ 1D -AR antagonist BMY-7378 (10 Ϫ7 M). As shown in Fig. 4C , in response to increasing Phe alone, adult CA showed a typical increase in vascular tension. After ␣ 1D -AR inhibition, however, the maximal Phe-induced contractile response and [Ca 2ϩ ] i was attenuated compared with control (P Ͻ 0.01 for each; Fig. 4, C and  D) . As shown in Fig. 4A , in response to increasing Phe alone, fetal CA showed a typical contraction. In the presence of ␣ 1D -AR antagonist BMY-7378, the Phe-induced contractile and [Ca 2ϩ ] i responses were decreased, but significantly less so than those in adult (see Table 2 for K B values for BMY-7378). Protein abundance of ␣ 1 -AR subtypes. Figure 5A illustrates the ␣ 1 -AR profiles from whole cell extracts that were subjected to Western immunoblot analysis using enhanced chemiluminescence substrate, as described in METHODS. As shown, adult ovine CA express relatively abundant amounts of each of the subtype ␣ 1A -, ␣ 1B -, and ␣ 1D -AR. In contrast, near-term fetal CA demonstrated low levels of the three ␣ 1 -AR subtypes. Immunoblots of ␣-actin are shown as an internal control. Of interest, in fetal CA the ␣ 1D -AR subtype is expressed to a relatively greater degree than the other two subtypes (Fig. 5A) . measured Phe-induced Ins(1,4,5)P 3 levels (pmol·min Ϫ1 ·mg protein Ϫ1 ) in fetal and adult CA. As shown in Fig. 5B , in adult CA 3 ϫ 10 Ϫ5 M Phe stimulation resulted in a significant increase in Ins(1,4,5)P 3 levels, being 54 Ϯ 3 from a basal value of 27 Ϯ 2 (P Ͻ 0.01). Similarly in fetal CA, Phe induced a significant increase in Ins(1,4,5)P 3 levels, being 47 Ϯ 4 from 28 Ϯ 3 (P Ͻ0.01). In the presence of the ␣ 1A -AR antagonist 5-MU (10 Ϫ8 M), Phe did not increase Ins(1,4,5)P 3 levels significantly in either fetal or adult CA, which were 30 Ϯ 5 and 37 Ϯ 4, respectively. Similarly, in the presence of another ␣ 1A -AR antagonist, WB-4101 (10 Ϫ5 M), Phe did not induce significant Ins(1,4,5)P 3 responses, levels being 38 Ϯ 2 in the adult and 31 Ϯ 5 in the fetus. These Ins(1,4,5)P 3 levels were statistically similar to those of control (unstimulated) arteries. Additionally, in the presence of the specific ␣ 1B -AR antagonist CEC (10 Ϫ5 M), the Phe-induced Ins(1,4,5)P 3 values in adult and fetal CA did not differ significantly from control (30 Ϯ 2 and 28 Ϯ 3, respectively). Of interest, in both adult and fetal CA the selective ␣ 1D -AR antagonist BMY-7338 (10 Ϫ5 M) caused significantly less inhibition of the Phe-induced Ins(1,4,5)P 3 responses. In adult CA, Ins(1,4,5)P 3 responses induced by Phe ϩ BMY-7338 were significantly less than those induced by Phe alone, whereas in fetal CA Ins(1,4,5)P 3 levels showed no significant difference from control (Fig. 5B) .
␣ 1 -AR subtypes and ERK1/2 interaction. Figure 6 , A-C, show the levels of activated (phosphorylated) ERK1/2 in fetal CA in the absence or presence of the ␣ 1 -AR subtype antagonists. In control experiments, the antagonists for ␣ 1A -AR (5-MU and WB-4104), for ␣ 1B -AR (CEC), and for ␣ 1D -AR (BMY-7378) alone had no significant effect on basal total or activated ERK1 and 2 levels (data not shown). In the fetal arteries, Phe stimulation (10 Ϫ5 M) showed a significant (100%) increase in both phosphorylated ERK1 and 2 (Fig. 6A) . Also, Phe in the presence of ␣ 1A -AR antagonists 5-MU (10 Ϫ8 M) or WB-4104 (10 Ϫ7 M) showed similar increases in phosphorylated ERK1/2 levels. In contrast, in the presence of CEC (10 Ϫ5 M; ␣ 1B -AR antagonist) or BMY-7378 (10 Ϫ7 M; ␣ 1D -AR antagonist), there was no significant Phe-induced phosphorylation of ERKs (Fig. 6 ). Figure 6 , B and C, show the densitometric analysis of phosphorylated-p44 (ERK1) and phosphorylated-p42 (ERK2) in fetal CA normalized to the ␣-actin band (n ϭ 4), which confirms these observations. By way of contrast, in adult CA (Fig. 6, D-F) , Phe stimulation (10 Ϫ5 M) showed no significant increase in activated ERKs. Also under basal conditions in the adult arteries, the antagonists 5-MU or WB-4101, CEC, and BMY-7378 showed no significant inhibition of activated ERK1/2 levels. In addition, in the adult vessels, none of the ␣ 1 -AR subtype inhibitors significantly affected the activated ERK levels after Phe (10 Ϫ5 M) stimulation (Fig. 6, D-F) .
DISCUSSION
In the present study, we have demonstrated several important findings regarding the role of ␣ 1 -AR subtypes in mediating contractile responses in fetal and adult CA. 1) Each of the three known ␣ 1 -AR subtypes is present in fetal and adult CA. Moreover, in fetal CA all three subtypes are present in significantly lower amounts than in the adult. Nonetheless, in fetal CA, ␣ 1D -AR are present in significantly greater amounts than the other two subtypes. 2) In adult CA, each of the three subtypes mediates a Phe-induced contractile response. In fetal CA, in contrast, ␣ 1A -AR is the major subtype involved in Phe-induced contractility. 3) In both fetal and adult CA, Phe stimulates increased Ins(1,4,5)P 3 responses with increased [Ca 2ϩ ] i . Moreover, in both fetal and adult CA, ␣ 1A -AR and ␣ 1B -AR inhibition completely blocked these Ins(1,4,5)P 3 responses. In contrast, in adult CA ␣ 1D -AR inhibition decreased the Ins(1,4,5)P 3 response to a much lesser extent compared with those produced by ␣ 1A -AR and ␣ 1B -AR inhibition (P ϭ 0.01). In fetal CA no inhibition of Ins(1,4,5)P 3 responses was observed in the presence of ␣ 1D -AR inhibitor. 4) In fetal, but not adult, CA, Phe stimulates phosphorylation of ERK1/2, and this Phe-mediated ERK phosphorylation was inhibited by ␣ 1B -AR and ␣ 1D -AR blockers. These novel and important findings provide a deeper understanding of the role of adrenergic-mediated cerebral contractility, which may be important in the regulation of CBF. The findings of differential roles of the ␣ 1 -AR subtypes may lead to development of specific therapeutic agents with fewer adverse effects during fetal life.
For a mechanistic overview, Fig. 7 presents a schema, based on both our present findings and other data (8) , for the role of specific ␣ 1 -AR subtype-mediated mechanisms in fetal and adult CA. In the fetus and the adult (Fig. 7, left) , the present study supports the canonical pathway of Ca 2ϩ -dependent contractility, with the ␣ 1A -and ␣ 1B -AR subtypes stimulating Ins(1,4,5)P 3 production to increase [Ca 2ϩ ] i and activate myosin light chain (MLC) kinase (MLCK) and MLC 20 , thus stimulating vascular contraction by thick and thin filament interaction. Of importance, ␣ 1B -AR and ␣ 1D -AR function quite differently in the fetus (Fig. 7, right) . In fetal CA, Phe stimulates the ␣ 1B -AR and ␣ 1D -AR subtypes, which in turn activate ERK1/2 by a mechanism as yet unclear. By activation of ERK directly (with or without involvement of other kinases), ␣ 1B -AR and ␣ 1D -AR in the fetus may play a critical role in vascular development by stimulating maturation and growth of SMCs. In addition, the ␣ 1B -AR subtype-mediated production of diacylglycerol (DAG) activates PKC, which leads to phosphorylation in MAPK and ERK1/2. Thus the several ␣ 1 -AR subtypes function in a very different manner in the fetus compared with the adult. A grasp of these interactions, along with subtype-specific information, is essential for understanding the regulation of cerebrovascular tone and CBF. This is important, as the unique features of these subtypes may play a role in dysregulation of CBF in the fetus and premature newborn, as well as in the adult. Quite obviously, we yet have much to learn in regard to ␣ 1 -AR subtypes and their changing role with maturation. A caveat of these studies concerns the relative selectivity of the purported pharmacological antagonists for the several ␣ 1 -AR subtypes (53), because subtypeselective agents may not be overly selective and some interact with other adrenergic and nonadrenergic receptors. Both ␣ 1A -AR antagonists, 5-MU (11, 31) and WB-4101 (38) , are relatively selective, although they differ in action. In turn, the alkylating agent CEC (16) and BMY-7378 (7) have been demonstrated to be quite selective antagonists for ␣ 1B -AR and ␣ 1D -AR, respectively.
␣ 1 -AR subtype expression and vascular reactivity. The International Union of Pharmacology has designated ␣ 1 -AR subtypes as ␣ 1A/a , ␣ 1B/b , and ␣ 1D/d , with the uppercase letters representing the pharmacologically identified subtypes and the lowercase letters representing the subtype molecular clones (19) . Important mediators of sympathetic nervous response, the ␣ 1 -AR are widely distributed throughout many cell types, and in SMCs regulate vascular tone and blood flow (53) . In SMCs, the ␣ 1 -AR subtypes and their levels vary considerably in their distribution in various circulatory beds, in different-size vessels of a given vascular bed, and in different species (16, 36, 41, 48) . The present findings of a paucity of expression of the several ␣ 1 -AR subtypes in the fetal CA agrees with the concept of an increase in ␣ 1 -AR density with development (13, 32) . For instance, in rats with aging from 1 mo to 24 mo, both ␣ 1B -AR mRNA and protein levels of ␣ 1A -AR increased, while ␣ 1D -AR levels remained constant (13) . Moreover, in another report, after 10 wk of age ␣ 1D -AR have been reported to decrease, so that by 12 mo of age vasoconstrictor response to the ␣ 1A -AR subtype was predominant (32) . Also, in comparing 7-day-old and adult rats, each of the three subtypes increased in brain tissue, ␣ 1B -AR increased in heart but decreased in liver, and none of the subtypes changed significantly in kidney (43) .
␣ 1 -AR subtypes and intracellular signaling. Differences in ␣ 1 -AR subtype expression levels with development would be anticipated to have important physiological significance. Moreover, coupling of different ␣ 1 -AR with different signal transduction pathways increases such significance. Relatively few studies have examined these relations in the vascular smooth muscle, and none to our knowledge in CA, much less comparing the immature organism with the adult. In adult but not in fetal CA, it has been well documented that the three ␣ 1 -AR subtypes, members of the G q / 11 protein-coupled receptors, activate PLC-␤ to hydrolyze phosphatidylinositol 4,5-bisphosphate to Ins(1,4,5)P 3 and DAG, the latter of which, in turn, activates PKC. ␣ 1D -AR inhibition appears to cause modest decrease in Phe-induced Ins(1,4,5)P 3 responses, however, the contractility and Ca 2ϩ responses being inhibited to a significant extent. ␣ 1D -AR may be mediating these effects through other signal transduction pathways such as RhoA/Rho kinase and/or activation of L-type Ca 2ϩ channels and so forth. In fetal but not adult CA we also observed a pronounced increase in ERK phosphorylation with Phe, which was inhibited by ␣ 1B -AR and ␣ 1D -AR antagonists. Of interest, recently we have shown (8) that PKC also differentially activates ERK in fetal and adult CA. Other reports indicate that GPCR such as ␣ 1 -AR acting through G q / 11 also can activate the MAPK pathway via PKC and/or the Ras/Raf pathway by adapter proteins (30, 54) . In 1-to 2-day-old rat cardiac myocytes, MAPK phosphorylation appeared to be mediated by the ␣ 1B -AR (45) . To our knowledge, no studies in cerebrovascular SMCs have examined the relation of ␣ 1 -AR subtypes to activation of the MAPK cascade and downstream effects of cell growth and differentiation, and this requires further investigation. In cultured rat aortic SMCs, protein synthesis and hypertrophy appeared to be mediated by the prominent ␣ 1B -AR (3). Similarly in rabbit aortas, ␣ 1B -AR stimulated protein synthesis (44) . Along this line, in cultured rat thoracic aorta SMCs stably transfected with full-length ␣ 1 -AR cDNAs, the ␣ 1D -AR appeared to couple to MAPK-mediated protein synthesis and cell growth, and these responses could be inhibited by the MEK inhibitor PD-98059 (46) .
Perspectives and significance. The present study extends our understanding of the adrenergic receptor pathway in CA contractility. It is a logical extension of our previous findings and illustrates a small facet of this complexity, e.g., that having to do with developmental maturation. The study provides details regarding maturational shift in expression and functions of ␣ 1 -AR subtypes, as well as coupling with downstream pathways. However, this study makes more apparent the complexity of intracellular signaling pathways and raises a number of 
